Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

IPO Preview: NewLink Genetics
Seeking Alpha
Tuesday, November 8, 2011 - 7:22pm
tags:
NewLink Genetics, IPO, HyperAcute Pancreas, HyperAcute Lung
Pfizer: Strong And Safe With Catalysts
Pfizer: Strong And Safe With Catalysts
Tuesday, November 8, 2011 - 7:19pm
tags:
Pfizer, JNJ, Abbott Laboratories
Pfizer, Ranbaxy Sued By 11 Pharmacies Over Lipitor Prices
Bloomberg
Tuesday, November 8, 2011 - 7:18pm
tags:
Pfizer, Ranbaxy, Lipitor, generics
Study: Deal terms getting richer as pharmas stockpile antibody tech
Fierce Biotech
Tuesday, November 8, 2011 - 11:06am
tags:
antibodies, autoimmune disease, CNS, Roche, AstraZeneca, Bristol-Myers Squibb, Novartis, Pfizer, Merck, mAb
Healthcare Sector: Noteworthy Insider Buys And Sells
Seeking Alpha
Tuesday, November 8, 2011 - 11:03am
tags:
Alkermes, Bristol-Myers Squibb, Celgene, Gilead, Illumina, Inhibitex, JNJ, United Health, Seattle Genetics, Pharmasset
Five Drugs That Own The Prostate Pipeline
Seeking Alpha
Tuesday, November 8, 2011 - 11:00am
tags:
prostate cancer, Dendreon, Provenge, Zytiga, JNJ, Medivation, MVD 3100, Exelixis, cabozantinib, Curtirsen, Teva Pharmaceuticals, OncoGenex
Teva sacks 1,500 Cephalon workers
Ynet
Tuesday, November 8, 2011 - 10:55am
tags:
Teva Pharmaceuticals, layoffs, Cephalon
Pfizer Gets Court Fees from Teva for Defending Viagra Patent
Courthouse News
Tuesday, November 8, 2011 - 10:37am
tags:
patents, Pfizer, Teva Pharmaceuticals, Viagra
NeurogesX Reports Positive Phase 2 Results for NGX-1998 for Treatment of Postherpetic Neuralgia
Yahoo
Tuesday, November 8, 2011 - 10:35am
tags:
NGX-1998, NeurogesX, postherpetic neuralgia
Santarus' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, November 8, 2011 - 10:34am
tags:
earnings, Santarus
Insmed Inc. Earnings Cheat Sheet: Loss Widens, Falls Below Estimates
Yahoo/Wall St. Cheat Sheet
Tuesday, November 8, 2011 - 10:33am
tags:
Insmed, earnings
Vivus Posts Narrower Loss
Yahoo/Zacks.com
Tuesday, November 8, 2011 - 10:33am
tags:
earnings, Vivus
Targacept Depression Drug Fails Late-Stage Study
TheStreet.com
Tuesday, November 8, 2011 - 10:32am
tags:
depression, Targacept, AstraZeneca, TC-5214
Blockbuster Breakup: Amylin Buys Out Lilly's Exenatide Rights
Motley Fool
Tuesday, November 8, 2011 - 10:31am
tags:
diabetes, Eli Lilly, exenatide, Amylin
Baxter says immune drug reduced infections
Yahoo/AP
Monday, November 7, 2011 - 9:19pm
tags:
Baxter, HyQ, immune disorders
Nabi reviewing options after smoking vaccine fails
Yahoo/AP
Monday, November 7, 2011 - 9:17pm
tags:
Nabi, smoking cessation, vaccine, NicOx
Bristol-Myers Approved to Market Erbitux for Wider Cancer Use
Bloomberg
Monday, November 7, 2011 - 9:15pm
tags:
Erbitux, Bristol-Myers Squibb, ImClone, Eli Lilly, head and neck cancer
Amgen Stock Rises on New Buyback Plan, But How About the Debt?
Barron's
Monday, November 7, 2011 - 9:13pm
tags:
Amgen, debt, stock buyback
1 Reason the Street Should Love Eli Lilly's Earnings
Motley Fool
Monday, November 7, 2011 - 9:12pm
tags:
earnings, Eli Lilly
Lipitor's $131B lifetime sales dwarf other megablockbusters
Fierce Pharma
Monday, November 7, 2011 - 12:09pm
tags:
Lipitor, Pfizer, statins, drug data, Plavix, Zocor, Seretide, Advair, Nexium

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.